A probabilistic method for the estimation of residual risk in donated blood

Biostatistics

Volumn 15, Issue 4, 2014, Pages 620-635

  Bish, Ebru K ^a   Ragavan, Prasanna K ^a   Bish, Douglas R ^a   Slonim, Anthony D ^b   Stramer, Susan L ^c  

^a State University   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c AMERICAN RED CROSS   (United States)

Author keywords

Blood donation; Incidence window period model; Optimization; Risk estimation

Indexed keywords

BLOOD DONOR; BLOOD SAFETY; COST BENEFIT ANALYSIS; ECONOMICS; HUMAN; INCIDENCE; PROBABILITY; RISK ASSESSMENT; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

BLOOD DONORS; BLOOD SAFETY; COST-BENEFIT ANALYSIS; HUMANS; INCIDENCE; MODELS, STATISTICAL; PROBABILITY; RISK ASSESSMENT;

EID: 84929506249     PISSN: 14654644     EISSN: 14684357     Source Type: Journal    
DOI: 10.1093/biostatistics/kxu017     Document Type: Article

References (26)

1. BISH, D. R., and BISH., E. K., XIE, S. R. AND SLONIM, A. D. (2011). Optimal selection of screening assays for infectious agents in donated blood. IIE Transactions on Healthcare Systems Engineering 1(2), 67-90.
2. BROOKMEYER, R. (2009). Should biomarker estimates of HIV incidence be adjusted? AIDS 23(4), 485-491.
3. BURD, E. M. (2010). Validation of laboratory-developed molecular assays for infectious diseases. Clinical Microbiology Reviews 23(3), 550-576.
4. BUSCH, M. P., and GLYNN., S. A., STRAMER, S. L., STRONG, D. M., CAGLIOTI, S., WRIGHT. D. J., PAPPALARDO, B. AND KLEINMAN, S. H. (2005). A new strategy for estimating risks of transfusion-transmitted viral infections based on rates of detection of recently infected donors. Transfusion 45(2), 254-264.
5. BUSCH, M. P. AND SATTEN, G. A. (1997). Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure. The American Journal of Medicine 102(5), 117-124.
6. FIEBIG, E. W., and WRIGHT., D. J., RAWAL, B. D., GARRETT, P. E., and SCHUMACHER., R. T., PEDDADA, L., HELDEBRANT, C., SMITH, R., CONRAD, A., KLEINMAN, S. H. and others (2003). Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17(13), 1871-1879.
7. GANEM, D. AND PRINCE, A. M. (2004). Hepatitis B virus infection: natural history and clinical consequences. New England Journal of Medicine 350(11), 1118-1129.
8. GONCALEZ, T. T., and SABINO., E. C., MURPHY, E. L., CHEN, S., CHAMONE, D. A. F. AND MCFARLAND, W. (2006). Human immunodeficiency virus test-seeking motivation in blood donors, São Paulo, Brazil. Vox Sanguinis 90(3), 170-176.
9. GREINACHER, A., FENDRICH, K., ALPEN, U. AND HOFFMANN, W. (2007). Impact of demographic changes on the blood supply: Mecklenburg-West Pomerania as a model region for Europe. Transfusion 47(3), 395-401.
10. JACKSON, B. R., and BUSCH., M. P., STRAMER, S. L. AND AUBUCHON, J. P. (2003). The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations. Transfusion 43(6), 721-729.
11. JOSEPH, L., GYORKOS, T. W. AND COUPAL, L. (1995). Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard. The American Journal of Epidemiology 141(3), 263-272.
12. KLEINMAN, S., and BUSCH., M. P., KORELITZ, J. J. AND SCHREIBER, G. B. (1997). The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection. Transfusion Medicine Reviews 11(3), 155-172.
13. LACKRITZ, E. M., and SATTEN., G. A., ABERLE-GRASSE, J., DODD, R. Y., and RAIMONDI., V. P., JANSSEN, R. S., LEWIS, W. F., NOTARI, E. P. AND PETERSEN, L. R. (1995). Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. New England Journal of Medicine 333(26), 1721-1725.
14. LIMMATHUROTSAKUL, D., JAMSEN, K., ARAYAWICHANONT, A., SIMPSON, J. A., and WHITE., L. J., LEE, S. J., WUTHIEKANUN, V., CHANTRATITA, N., CHENG, A., DAY, N. P. J. and others (2010). Defining the true sensitivity of culture for the diagnosis of melioidosis using Bayesian latent class models. PLoS One 5(8), e12485.
15. ORFINGER, B. (2010). Red Cross calls national blood shortage a disaster. http://www.redcross.org/news/inthenews/00/7-12a-00.html, Accessed in July 2010.
16. PEPE, M. S. (2003). The Statistical Evaluation of Medical Tests for Classification and Prediction. Oxford: Oxford University Press.
17. PREISER, W., and BRINK., N. S., HAYMAN, A., WAITE, J., BALFE, P. AND TEDDER, R. S. (2000). False-negative HIV antibody test results. Journal of Medical Virology 60(1), 43-47.
18. SATTEN, G. A. (1997). Steady-state calculation of the risk of HIV infection from transfusion of screened blood from repeat donors. Mathematical Biosciences 141(2), 101-113.
19. SCHREIBER, G. B., and BUSCH., M. P., KLEINMAN, S. H. AND KORELITZ, J. J. (1996). The risk of transfusion-transmitted viral infections. New England Journal of Medicine 334(26), 1685-1690.
20. TRIKALINOS, T. A. (2012). Options for summarizing medical test performance in the absence of a "gold standard". Journal of General Internal Medicine 27(1), 67-75.
21. US-FDA. (2011). Maintaining a safe and adequate supply of donated blood during a severe emergency. Blood Products Advisory Committee.
22. VAN HULST, M., HUBBEN, G., SAGOE, K., PROMWONG, C., PERMPIKUL, P., FONGSATITKUL, L., GLYNN, D. M., SIBINGA, C. T. S. AND POSTMA, M. J. (2009). Web interface-supported transmission risk assessment and cost-effectiveness analysis of postdonation screening: a global model applied to Ghana, Thailand, and the Netherlands. Transfusion 49(12), 2729-2742.
23. VAN SMEDEN, M., NAAKTGEBOREN, C. A., and REITSMA., J. B., MOONS, K. G. M. and DE GROOT, J. A. H. (2013). Latent class models in diagnostic studies when there is no reference standard: a systematic review. The American Journal of Epidemiology, kwt286.
24. WEUSTEN, J. A. M., VAN DRIMMELEN, H. A. J. AND LELIE, P. N. (2002). Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT. Transfusion 42(5), 537-548.
25. XIE, S. R., and BISH., D. R., BISH, E. K., SLONIM, A. D. AND STRAMER, S. L. (2012). Safety and waste considerations in donated blood screening. European Journal of Operational Research 217(3), 619-632.
26. YASUI, Y., YANAI, H., SAWANPANYALERT, P. AND TANAKA, H. (2002). A statistical method for the estimation of window-period risk of transfusion-transmitted HIV in donor screening under non-steady state. Biostatistics 3(1), 133-143.